论文部分内容阅读
麦迪霉素是中国医学科学院药物研究所和四川抗菌素工业研究所于1974年各自筛选到的两株链霉菌产生的一种新的大环内酯类抗菌素,由苏州第二制药厂、四川制药厂和上海第四制药厂协作试制,于1977年5月在苏州通过技术鉴定。经研究证明,麦迪霉素与国外近年发表的Medecamycin为同一物质。麦迪霉素对金黄色葡萄球菌、链球菌、肺炎双球菌和白喉杆菌等固紫染色阳性细菌有明显的抗菌作用,对部分耐红霉素的金黄色葡萄球菌有抑制作用。与红霉素不同,它是一种非诱导
Midecamycin is a new macrolide antibiotic produced by two strains of Streptomyces which were screened by Institute of Materia Medica, Chinese Academy of Medical Sciences and Institute of Antibiotics, respectively, in 1974. They are produced by Suzhou No.2 Pharmaceutical Factory, Sichuan Pharmaceutical Factory And the fourth pharmaceutical factory in Shanghai trial production, in May 1977 in Suzhou passed the technical appraisal. The study proved that, midecamycin and published in recent years, Medecamycin for the same substance. Midecamycin on Staphylococcus aureus, Streptococcus, Streptococcus pneumoniae and diphtheria bacteria and other solid purple staining positive bacteria have obvious antibacterial activity, some erythromycin resistant Staphylococcus aureus inhibited. Unlike erythromycin, it is a non-inducible